Atea Pharmaceuticals (AVIR) Q2 2026 Earnings

May 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.57
-0.51
-0.46
-0.4

Details

Expected EPS
-0.555
Actual EPS
-0.57
Surprise EPS
-0.01
Surprise Percent
-2.7%

Description

⁨Atea Pharmaceuticals⁩ (⁦AVIR⁩) has reported earnings of ⁦-0.57⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts